Monica Gandhi, MD, MPH

CFAR Leadership Positions

CFAR Mentees

CFAR Award

Publications

  1. Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos K, Deeks SG, Gandhi M, Havlir DV. The Effect of a "Universal Antiretroviral Therapy" Recommendation on HIV RNA Levels among HIV-Infected Patients Entering Care with a CD4 Count Greater than 500/Ál in a Public Health Setting. Clin Infect Dis. 2012 Sep 5. http://www.ncbi.nlm.nih.gov/pubmed/22955429
  2. Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, Aouizerat B. A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women. J Infect Dis. 2012 Nov; 206(9):1453-61. http://www.ncbi.nlm.nih.gov/pubmed/22927450
  3. Merenstein D, Wang C, Gandhi M, Robison E, Levine AM, Schwartz RM, Weber KM, Liu C. An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women. Complement Ther Med. 2012 Aug; 20(4):222-7. http://www.ncbi.nlm.nih.gov/pubmed/22579434
  4. Liu C, Wang C, Robison E, Levine AM, Gandhi M, Schwartz R, Weber KM, Merenstein D. Short-term Garlic Supplementation and Highly Active Antiretroviral Treatment Adherence, CD4+ Cell Counts, and Human Immunodeficiency Virus Viral Load. Altern Ther Health Med. 2012 Jan-Feb; 18(1):18-22. http://www.ncbi.nlm.nih.gov/pubmed/22516847
  5. Chandy S, Singh G, Heylen E, Gandhi M, Ekstrand ML. Treatment switching in South Indian patients on HAART: what are the predictors and consequences? AIDS Care. 2011 May; 23(5):569-77. http://www.ncbi.nlm.nih.gov/pubmed/21293988
  6. Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM. Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2009 Apr 15; 50(5):482-91. http://www.ncbi.nlm.nih.gov/pubmed/19408353
  7. Merenstein D, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J, Plankey MW. Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. AIDS Patient Care STDS. 2009 Apr; 23(4):289-96. http://www.ncbi.nlm.nih.gov/pubmed/19243274
  8. Gandhi M, Ameli N, Bacchetti P, Gange SJ, Anastos K, Levine A, Hyman CL, Cohen M, Young M, Huang Y, Greenblatt RM. Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS. 2009 Feb 20; 23(4):471-8. http://www.ncbi.nlm.nih.gov/pubmed/19165084
  9. Huang Y, Gandhi M, Greenblatt RM, Gee W, Lin ET, Messenkoff N. Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008 Nov; 22(21):3401-9. http://www.ncbi.nlm.nih.gov/pubmed/18837069
  10. Merenstein D, Yang Y, Schneider MF, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M, Liu C. Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation. Altern Ther Health Med. 2008 Sep-Oct; 14(5):18-22. http://www.ncbi.nlm.nih.gov/pubmed/18780580
  11. Szczech LA, Golub ET, Springer G, Augenbraun M, Young M, Gandhi M, Gillepsie BS, Anastos K. Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection. J Acquir Immune Defic Syndr. 2008 Jul 1; 48(3):360-1. http://www.ncbi.nlm.nih.gov/pubmed/18580338
  12. Merenstein DJ, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi M, Richardson J, Plankey MW. Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. Pediatrics. 2008 Apr; 121(4):e787-93. http://www.ncbi.nlm.nih.gov/pubmed/18381507
  13. Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy. Clin Infect Dis. 2008 Jan 15; 46(2):305-12. http://www.ncbi.nlm.nih.gov/pubmed/18171267
  14. Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Curr HIV/AIDS Rep. 2007 Dec; 4(4):181-6. http://www.ncbi.nlm.nih.gov/pubmed/18366949
  15. Liu C, Lerch V, Weber K, Schneider MF, Sharp GB, Gorapaju L, Sharma A, Levine A, Gandhi M, Merenstein D. Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. J Altern Complement Med. 2007 Dec; 13(10):1053-6. http://www.ncbi.nlm.nih.gov/pubmed/18166114
  16. Wilson TE, Feldman J, Vega MY, Gandhi M, Richardson J, Cohen MH, McKaig R, Ostrow D, Robison E, Gange SJ. Acquisition of new sexual partners among women with HIV infection: patterns of disclosure and sexual behavior within new partnerships. AIDS Educ Prev. 2007 Apr; 19(2):151-9. http://www.ncbi.nlm.nih.gov/pubmed/17411417
  17. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006 Jun; 96(6):1060-5. http://www.ncbi.nlm.nih.gov/pubmed/16670229
  18. Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, Greenblatt RM. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. AIDS. 2005 Nov 4; 19(16):1885-96. http://www.ncbi.nlm.nih.gov/pubmed/16227797
  19. Silverberg MJ, Gore ME, French AL, Gandhi M, Glesby MJ, Kovacs A, Wilson TE, Young MA, Gange SJ. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 1; 39(5):717-24. http://www.ncbi.nlm.nih.gov/pubmed/15356788
  20. Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44:499-523. http://www.ncbi.nlm.nih.gov/pubmed/14744256
  21. Gandhi M, Greenblatt RM. Human herpesvirus 8, Kaposi's sarcoma, and associated conditions. Clin Lab Med. 2002 Dec; 22(4):883-910. http://www.ncbi.nlm.nih.gov/pubmed/12489286
  22. Gandhi M, Greenblatt RM. Hair it is: the long and short of monitoring antiretroviral treatment. Ann Intern Med. 2002 Oct 15; 137(8):696-7. http://www.ncbi.nlm.nih.gov/pubmed/12379072
  23. Gandhi M, Bacchetti P, Miotti P, Quinn TC, Veronese F, Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2002 Aug 1; 35(3):313-22. http://www.ncbi.nlm.nih.gov/pubmed/12115098